News
EW
74.81
+1.19%
0.88
EW Quantitative Stock Analysis - Benjamin Graham
NASDAQ · 1d ago
Is the Options Market Predicting a Spike in Edwards (EW) Stock?
Barchart · 3d ago
Deutsche Bank Sticks to Its Buy Rating for Edwards Lifesciences (EW)
TipRanks · 4d ago
Edwards Lifesciences: Competitive Pressures and Valuation Concerns Lead to Sell Rating
TipRanks · 4d ago
Assessing Edwards Lifesciences: Insights From 20 Financial Analysts
Benzinga · 6d ago
Edwards Lifesciences Raised to Buy From Neutral by B of A Securities
Dow Jones · 6d ago
Edwards Lifesciences Price Target Raised to $90.00/Share From $82.00 by B of A Securities
Dow Jones · 6d ago
B of A Securities Upgrades Edwards Lifesciences to Buy, Raises Price Target to $90
Benzinga · 6d ago
Edwards Lifesciences upgraded to Buy from Neutral at BofA
TipRanks · 6d ago
Weekly Report: what happened at EW last week (1209-1213)?
Weekly Report · 12/16 09:03
Levi & Korsinsky Reminds Edwards Lifesciences Corporation Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 13, 2024 - EW
PR Newswire · 12/13 10:45
Faruqi & Faruqi Reminds Edwards Lifesciences Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 13, 2024 - EW
PR Newswire · 12/12 17:07
Pioneer Fundamental Growth Fund Q3 2024 Performance And Market Commentary
Seeking Alpha · 12/12 15:56
FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Edwards Lifesciences Corporation
Barchart · 12/12 13:34
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Edwards Lifesciences Corporation (EW)
Barchart · 12/12 12:42
Edwards Lifesciences Corporation Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm Before December 13, 2024 to Discuss Your Rights - EW
PR Newswire · 12/12 10:45
Is Becton, Dickinson and Company Stock Underperforming the Dow?
Barchart · 12/12 04:54
EW Investors Have Opportunity to Lead Edwards Lifesciences Corporation Securities Fraud Lawsuit
PR Newswire · 12/12 01:31
Edwards Lifesciences Is Maintained at Buy by Citigroup
Dow Jones · 12/11 19:18
More
Webull provides a variety of real-time EW stock news. You can receive the latest news about Edwards Lifesciences Corp through multiple platforms. This information may help you make smarter investment decisions.
About EW
Edwards Lifesciences Corporation is a global structural heart innovation company. The Company is engaged in patient-focused medical innovations for structural heart disease and invests in research and development to transform care for those impacted by structural heart disease. Its products are categorized into groups, including Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral and Tricuspid Therapies (TMTT), and Surgical Structural Heart (Surgical). It develops transcatheter heart valve replacement technologies designed for the minimally invasive replacement of aortic heart valves. The Edwards SAPIEN family of valves includes the Edwards SAPIEN 3, the Edwards SAPIEN 3 Ultra, and the Edwards SAPIEN 3 Ultra RESILIA systems, are catheter-based approaches for treating severe symptomatic aortic stenosis. Its PASCAL PRECISION and Cardioband transcatheter valve repair systems are commercially available in Europe for mitral and tricuspid valve repair.